NC410
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for NC410, covering 2024-07-25 to 2026-08-13. Get the full timeline:
Most recent: Clinical Trial Results: A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]